Abstract
Thrombin (EC 3.4.21.5) is a central, bioregulatory enzyme in thrombosis and hemostasis (1, 2). Thrombin activities are diverse and include fibrin clot formation (3) and stabilization (4), platelet and other cellular activation (5–7), and both positive and negative control of its own zymogen activation (8, 9). When compared to other serine proteinases of the coagulation and fibrinolytic systems, thrombin is unique in lacking the majority of its propiece (prothrombin fragment F 1.2) following zymogen activation (10, 11). Accordingly, the various specificities of thrombin must be accommodated solely within the enzyme moiety consisting of A and B chains.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J. W. Fenton IIAnn. NYAcad. Sci., 485:5–15 (1986).
J. W. Fenton IISemin. Thrombos. Hemostas., 12:200–208 (1986).
B. Blomback,in: Plasma Proteins (B. Blomback, and L. A., Hanson, eds.) pp. 223–253, Wiley, New York (1979).
L. Lorand, and K. Konishi, Arch. Biochem. Biophys., 105:58–67 (1964).
D. M. Tollefsen, J. R. Feagler, and P. W. Majerus, J. Biol. Chem., 249:2646–2651 (1974).
G. M. RodgersFASEB J., 2:116–123 (1988).
R. W. ColmanBiochemistry, 8:1438–1445 (1969).
C. T. EsmonScience, 235:1348–1352 (1987).
C. T. Esmon, W. G. Owen, D. L. Duiguid, and C. M. Jackson, Biochim. Biophys. Acta, 310:289–294 (1973).
S. J. F. Degen, R. T. A. MacGillivray, and E. W. Davie, Biochemistry, 22:2087–2097 (1983).
M. J. Rabiet, A. Blashill, B. Furie, and B. C. Furie, J. Biol. Chem., 261:13210–13215 (1986).
J.-Y. Chang, Eur. J. Biochem., 151:217–223 (1985).
J. W. Fenton IISemin. Thrombos. Hemostas., 15:265–268 (1989).
J. W. Fenton II J. I. Witting, C. Pouliott, and J. Fareed, Ann. NY Acad. Sci., 556:158–165 (1989).
T.-L. Chang, R. D. Feinman, B. H. Landis, and J. W. Fenton IIBiochemistry, 18:113–119 (1979).
S. D. Lewis, L. Lorand, J. W. Fenton II, and J. A. Shafer, Biochemistry, 26:7597–7603 (1987).
J. Dodt, H. P. Muller, U. Seemuller, and J.-Y. Chang, FEBS Lett., 165:180–184 (1984).
F. MarkwardtBiomed. Biochim. Acta, 44:1007–1013 (1985).
J. W. Fenton II, B. H. Landis, D. A. Walz, D. H. Bing, R. D. Feinman, M. P. Zabinski, S. A. Sonder, L. J. Berliner, and J. S. Finlayson, in: The Chemistry and Physiology of Human Plasma Proteins (D. H. Bing, ed.) Pergamon Press, New York, pp. 151–183.
S. R. Stone, and J. HofsteengeBiochemistry, 25:4622–4628 (1986).
S. R. Stone, P. J. Braun, and J. Hofsteenge, Biochemistry, 26:4617–4624 (1987).
J.-Y. Chang, FEBS Lett., 164:307–313 (1983).
S. Bajusz, I. Fauszt, E. Barabas, N. Diosegi, and D. Bagdy,in: Peptides (U. Ragnarsson, ed.) Almqvist and Wiksell Int., Stockholm, pp. 473–476 (1984).
G. Noe, J. Hofsteenge, G. Rovelli, and S. R. Stone, J. Biol. Chem., 263:11729–11735 (1988).
J. L. Krstenansky, T. J. Owen, M. T. Yates, and S. J. T. Mao, J. Med. Chem., 30:1688–1691 (1987).
D. Bagdy, E. Barabas, L. Graf, T. Ellebaek, and S. Magnusson, Methods Enzymol., 45:669–678 (1976).
J. Dodt, S. Kohler, and A. BaiciFEBS Lett., 229:87–90 (1988).
R. P. Harvey, E. Degryse, L. Stefani, F. Schamber, J. P. Cazenave, M. Courtney, P. Tolstoshev, and J. P. Lecocq, Proc. Natl. Acad. Sci. USA, 83:1084–1088 (1986).
G. Loison, A. Findeli, S. Bernard, M. Nguyen-Juilleret, M. Marquet, N. Riejl-Bellon, D. Carvallo, L. Guerra-Santos, S. W. Brown, M. Courtney, C. Roitsch, and Y. Lemoine, Biotechnology, 6:72–77 (1988).
J. L. Krstenansky, and S. J. T. Mao, FEBS Lett., 211:10–16 (1987).
J. M. Maraganore, B. Chao, M. L. Joseph, J. Jablonski, and K. L. Ramachandran, J. Biol. Chem., 264:8692–8698 (1989).
J. A. Jakubowsky, and J. M. MaraganoreBlood, 72:1213 (abtract) (1988).
J. A. Jakubowsky, and J. M. Maraganore, Blood, 75:399–406 (1990).
S. M. Prescott, A. R. Seeger, G A Zimmerman, T. M. MacIntyre, and J. M. Maraganore, J. Biol. Chem., in press (1990).
P. Bourdon, and J. M. Maraganore, Thromb. and Haemostas.,62:533 (abstract) (1989).
P. Bourdon, J. W. Fenton II, and J. M. Maraganore, Biochemistry, in press (1990).
W. Bode, I. Mayr, U. Baumann, R. Huber, S. R. Stone, and J. Hofsteenge, EMBO J., 8:3467–3475 (1989).
B. Furie, D. H. Bing, R. J. Feldmann, D. J. Robison, J. P. Burnier, and B. C. Furie, J. Biol. Chem., 257:3875–3882 (1982).
T. M. Palabrica, M. J. Aronovitz, J. M. Maraganore, and M. A. Konstam, Thrombos. and Hemostas., 62:434 (abstract) (1989).
Y. Cadroy, J. M. Maraganore, S. R. Hanson, and L. A. Harker, Thrombos. and Haemostas., 62:188 (abstract) (1989).
Y. Cadroy, J. M. Maraganore, S. R. Hanson, and L. A. Harker, Proc. Natl. Acad. Sci. USA, submitted (1989).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Maraganore, J.M., Fenton, J.W. (1990). Thrombin Inhibition by Synthetic Hirudin Peptides. In: Liu, C.Y., Chien, S. (eds) Fibrinogen, Thrombosis, Coagulation, and Fibrinolysis. Advances in Experimental Medicine and Biology, vol 281. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3806-6_17
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3806-6_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6697-3
Online ISBN: 978-1-4615-3806-6
eBook Packages: Springer Book Archive